Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
J&J must pay $1.1B for misleading doctors about Risperdal
San Francisco Chronicle, April 12, 2012
Johnson & Johnson must pay more than $1.1 billion in fines, a judge ruled after an Arkansas jury found the company's officials misled doctors and patients about the risks of the antipsychotic drug Risperdal. Judge Tim Fox in Little Rock, Arkansas, today found J&J and its Janssen unit committed more than 238,000 violations of the state's Medicaid fraud laws by illegally marketing Risperdal over an almost four-year period starting in 2002. The penalty is the largest of the three handed down so far against New Brunswick, New Jersey-based J&J in state cases alleging the second-biggest maker of health products hid Risperdal's risks and tricked Medicaid regulators into paying more than they should have for the medicine.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- House Lawmakers Grill CMS Over Health Exchange Navigators
- How Chargemaster Data May Affect Hospital Revenue
- Hospitals Profit On Bloodstream Infections
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- ED Physicians Key to Half of Hospital Admissions
- Hospital Pricing Transparency a Marketing Game Changer
Leadership |
Finance |
Technology |
Physicians |
Community Hospitals |
Health Plans |
Marketing |
Quality |
Nursing |
HR
*MAGNET™, MAGNET RECOGNITION PROGRAM®, and ANCC MAGNET RECOGNITION® are trademarks of the American Nurses Credentialing Center (ANCC). The products and services of HCPro, Inc. and The Greeley Company are neither sponsored nor endorsed by the ANCC. The acronym "MRP" is not a trademark of HCPro or its parent company. HCPro, Inc. is not affiliated in any way with The Joint Commission, which owns the JCAHO (Joint Commission on Accreditation of Healthcare Organizations) and Joint Commission trademarks, the Accreditation Council for Graduate Medical Education, which owns the ACGME trademark, or the Accreditation Association for Ambulatory Health Care (AAAHC).